Man Group’s Heron Therapeutics HRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | – | Sell |
-43,000
| Closed | -$246K | – | 2104 |
|
2022
Q1 | $246K | Buy |
+43,000
| New | +$246K | ﹤0.01% | 1790 |
|
2020
Q3 | – | Sell |
-315,161
| Closed | -$4.64M | – | 1813 |
|
2020
Q2 | $4.64M | Buy |
+315,161
| New | +$4.64M | 0.02% | 709 |
|
2020
Q1 | – | Sell |
-163,328
| Closed | -$3.84M | – | 1687 |
|
2019
Q4 | $3.84M | Buy |
+163,328
| New | +$3.84M | 0.01% | 1091 |
|
2019
Q3 | – | Sell |
-29,036
| Closed | -$540K | – | 1829 |
|
2019
Q2 | $540K | Sell |
29,036
-15,004
| -34% | -$279K | ﹤0.01% | 1651 |
|
2019
Q1 | $1.08M | Sell |
44,040
-16,742
| -28% | -$409K | ﹤0.01% | 1549 |
|
2018
Q4 | $1.58M | Buy |
+60,782
| New | +$1.58M | 0.01% | 1291 |
|
2018
Q3 | – | Sell |
-18,432
| Closed | -$716K | – | 2129 |
|
2018
Q2 | $716K | Buy |
+18,432
| New | +$716K | ﹤0.01% | 1691 |
|